BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29941360)

  • 1. Digital PCR (dPCR) analysis reveals that the homozygous c.315-48T>C variant in the FECH gene might cause erythropoietic protoporphyria (EPP).
    Brancaleoni V; Granata F; Missineo P; Fustinoni S; Graziadei G; Di Pierro E
    Mol Genet Metab; 2018 Aug; 124(4):287-296. PubMed ID: 29941360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria.
    Li C; Di Pierro E; Brancaleoni V; Cappellini MD; Steensma DP
    Clin Chem Lab Med; 2009; 47(1):44-6. PubMed ID: 19055472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
    Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
    Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria.
    Dickey AK; Quick C; Ducamp S; Zhu Z; Feng YA; Naik H; Balwani M; Anderson KE; Lin X; Phillips JE; Rebeiz L; Bonkovsky HL; McGuire BM; Wang B; Chasman DI; Smoller JW; Fleming MD; Christiani DC
    Genet Med; 2021 Jan; 23(1):140-148. PubMed ID: 32873934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
    Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
    Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
    Risheg H; Chen FP; Bloomer JR
    Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of erythropoietic protoporphyria in South Africa.
    Parker M; Corrigall AV; Hift RJ; Meissner PN
    Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
    Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism.
    Chiara M; Primon I; Tarantini L; Agnelli L; Brancaleoni V; Granata F; Bollati V; Di Pierro E
    Genet Med; 2020 Jan; 22(1):35-43. PubMed ID: 31273344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
    Oustric V; Manceau H; Ducamp S; Soaid R; Karim Z; Schmitt C; Mirmiran A; Peoc'h K; Grandchamp B; Beaumont C; Lyoumi S; Moreau-Gaudry F; Guyonnet-Dupérat V; de Verneuil H; Marie J; Puy H; Deybach JC; Gouya L
    Am J Hum Genet; 2014 Apr; 94(4):611-7. PubMed ID: 24680888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietic protoporphyria: a family study and report of a novel mutation in the FECH gene.
    Morais P; Mota A; Baudrier T; Trigo F; Oliveira JP; Cerqueira R; Palmeiro A; Tavares P; Azevedo F
    Eur J Dermatol; 2011; 21(4):479-83. PubMed ID: 21659066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
    Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
    Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population.
    Colombo FP; Rossetti MV; Méndez M; Martínez JE; Enríquez de Salamanca R; del C Batlle AM; Parera VE
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):754-62. PubMed ID: 22591014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
    Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
    Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.
    Long ZB; Wang YW; Yang C; Liu G; Du YL; Nie GJ; Chang YZ; Han B
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):813-820. PubMed ID: 27704751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH.
    Gouya L; Puy H; Robreau AM; Bourgeois M; Lamoril J; Da Silva V; Grandchamp B; Deybach JC
    Nat Genet; 2002 Jan; 30(1):27-8. PubMed ID: 11753383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.